UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034448
Receipt number R000039280
Scientific Title A research of the effect of mineral water consumption derived from Nagayu hot spring on prediabetes patients: a crossover study
Date of disclosure of the study information 2018/10/11
Last modified on 2019/10/29 13:40:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A research of the effect of mineral water consumption derived from Nagayu hot spring on prediabetes patients: a crossover study

Acronym

A research of the effect of mineral water consumption derived from Nagayu hot spring on prediabetes patients

Scientific Title

A research of the effect of mineral water consumption derived from Nagayu hot spring on prediabetes patients: a crossover study

Scientific Title:Acronym

A research of the effect of mineral water consumption derived from Nagayu hot spring on prediabetes patients

Region

Japan


Condition

Condition

Prediabetes

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of mineral water consumption derived from Nagayu hot spring on glycemic condition and/or intestinal environment in prediabetes patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical blood test (HbA1c, glycoalbumin, blood glucose and insulin)

Key secondary outcomes

- 16S metagenome analysis of gut microbiota
- Metabolome analysis of intestinal metabolites
- Gastrointestinal Symptom Rating Scale (GSRS), Japanese edition
- Questionnaire
- Body weight
- Body Mass Index (BMI)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Group A: Consumption of control water for 14 days. Consumption of 500 ml of control water divided into thrice daily (30-60 minutes before breakfast, lunch, and dinner)

Group B: Consumption of mineral water that collected from Nagayu hot spring for 14 days. Consumption of 500 ml of mineral water divided into thrice daily (30-60 minutes before breakfast, lunch, and dinner)

Interventions/Control_2

Group A: Consumption of mineral water that collected from Nagayu hot spring for 14 days. Consumption of 500 ml of mineral water divided into thrice daily (30-60 minutes before breakfast, lunch, and dinner)

Group B: Consumption of control water for 14 days. Consumption of 500 ml of control water divided into thrice daily (30-60 minutes before breakfast, lunch, and dinner)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.
2) Males and females who live in Taketa city.
3) Subjects whose HbA1c (NGSP) values are ranged from 5.6 to 6.4% in principle.

Key exclusion criteria

1) Subjects who frequently consume medicine for diabetes.
2) Subjects who frequently consume mineral water that collected from Nagayu hot spring.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Shinji
Middle name
Last name Fukuda

Organization

Metabologenomics, Inc.

Division name

Headquarters

Zip code

997-0052

Address

246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan

TEL

+81-235-64-0330

Email

research@metagen.co.jp


Public contact

Name of contact person

1st name Shinnosuke
Middle name
Last name Murakami

Organization

Metabologenomics, Inc.

Division name

Headquarters

Zip code

997-0052

Address

246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan

TEL

+81-235-64-0330

Homepage URL


Email

research@metagen.co.jp


Sponsor or person

Institute

Metabologenomics, Inc.

Institute

Department

Personal name



Funding Source

Organization

Japan health and research institute

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Health & Research Institute

Address

Garo Building 8F, 3-1-4, Nihonbashi, Chuo-ku, Tokyo, Japan

Tel

03-5290-1621

Email

info@jph-ri.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

30

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 10 Month 05 Day

Date of IRB

2018 Year 09 Month 28 Day

Anticipated trial start date

2018 Year 10 Month 11 Day

Last follow-up date

2018 Year 12 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 11 Day

Last modified on

2019 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039280


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name